Sino Biological,Inc. Statistics
Total Valuation
SHE:301047 has a market cap or net worth of CNY 11.18 billion. The enterprise value is 8.26 billion.
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Sep 21, 2026 |
Share Statistics
SHE:301047 has 121.64 million shares outstanding. The number of shares has decreased by -1.52% in one year.
| Current Share Class | 121.64M |
| Shares Outstanding | 121.64M |
| Shares Change (YoY) | -1.52% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 55.81% |
| Owned by Institutions (%) | 2.41% |
| Float | 43.30M |
Valuation Ratios
The trailing PE ratio is 62.44 and the forward PE ratio is 55.04.
| PE Ratio | 62.44 |
| Forward PE | 55.04 |
| PS Ratio | 14.12 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.30 |
| P/FCF Ratio | 203.71 |
| P/OCF Ratio | 52.17 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 37.09, with an EV/FCF ratio of 150.48.
| EV / Earnings | 46.12 |
| EV / Sales | 10.43 |
| EV / EBITDA | 37.09 |
| EV / EBIT | 62.61 |
| EV / FCF | 150.48 |
Financial Position
The company has a current ratio of 21.73, with a Debt / Equity ratio of 0.01.
| Current Ratio | 21.73 |
| Quick Ratio | 21.05 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 0.75 |
| Interest Coverage | 55.36 |
Financial Efficiency
Return on equity (ROE) is 3.43% and return on invested capital (ROIC) is 5.01%.
| Return on Equity (ROE) | 3.43% |
| Return on Assets (ROA) | 1.52% |
| Return on Invested Capital (ROIC) | 5.01% |
| Return on Capital Employed (ROCE) | 2.52% |
| Weighted Average Cost of Capital (WACC) | 8.85% |
| Revenue Per Employee | 740,872 |
| Profits Per Employee | 167,511 |
| Employee Count | 1,069 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.82 |
Taxes
In the past 12 months, SHE:301047 has paid 35.91 million in taxes.
| Income Tax | 35.91M |
| Effective Tax Rate | 16.71% |
Stock Price Statistics
The stock price has increased by +20.69% in the last 52 weeks. The beta is 0.84, so SHE:301047's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +20.69% |
| 50-Day Moving Average | 114.02 |
| 200-Day Moving Average | 85.11 |
| Relative Strength Index (RSI) | 36.63 |
| Average Volume (20 Days) | 8,330,168 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301047 had revenue of CNY 791.99 million and earned 179.07 million in profits. Earnings per share was 1.47.
| Revenue | 791.99M |
| Gross Profit | 581.35M |
| Operating Income | 131.92M |
| Pretax Income | 214.98M |
| Net Income | 179.07M |
| EBITDA | 196.82M |
| EBIT | 131.92M |
| Earnings Per Share (EPS) | 1.47 |
Full Income Statement Balance Sheet
The company has 2.96 billion in cash and 41.14 million in debt, with a net cash position of 2.92 billion or 24.02 per share.
| Cash & Cash Equivalents | 2.96B |
| Total Debt | 41.14M |
| Net Cash | 2.92B |
| Net Cash Per Share | 24.02 |
| Equity (Book Value) | 5.17B |
| Book Value Per Share | 42.47 |
| Working Capital | 3.13B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 214.30 million and capital expenditures -159.42 million, giving a free cash flow of 54.89 million.
| Operating Cash Flow | 214.30M |
| Capital Expenditures | -159.42M |
| Depreciation & Amortization | 64.90M |
| Net Borrowing | -31.09M |
| Free Cash Flow | 54.89M |
| FCF Per Share | 0.45 |
Full Cash Flow Statement Margins
Gross margin is 73.40%, with operating and profit margins of 16.66% and 22.61%.
| Gross Margin | 73.40% |
| Operating Margin | 16.66% |
| Pretax Margin | 27.14% |
| Profit Margin | 22.61% |
| EBITDA Margin | 24.85% |
| EBIT Margin | 16.66% |
| FCF Margin | 6.93% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.18%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 2.18% |
| Dividend Growth (YoY) | -56.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 149.44% |
| FCF Payout Ratio | 487.56% |
| Buyback Yield | 1.52% |
| Shareholder Yield | 3.70% |
| Earnings Yield | 1.60% |
| FCF Yield | 0.49% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 1.9.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:301047 has an Altman Z-Score of 25.76 and a Piotroski F-Score of 6.
| Altman Z-Score | 25.76 |
| Piotroski F-Score | 6 |